On December 29, 2025, Aptevo Therapeutics Inc. completed a reverse stock split at a ratio of 1-for-18, meaning every 18 shares were consolidated into one share, effective immediately. This adjustment will impact all stockholders and will be reflected from December 30, 2025, on The Nasdaq Capital Market.